Home Cart 0 Sign in  
X

[ CAS No. 4441-30-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4441-30-9
Chemical Structure| 4441-30-9
Chemical Structure| 4441-30-9
Structure of 4441-30-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4441-30-9 ]

Related Doc. of [ 4441-30-9 ]

Alternatived Products of [ 4441-30-9 ]

Product Details of [ 4441-30-9 ]

CAS No. :4441-30-9 MDL No. :MFCD01713533
Formula : C7H15NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :VZKSLWJLGAGPIU-UHFFFAOYSA-N
M.W : 145.20 Pubchem ID :199576
Synonyms :

Calculated chemistry of [ 4441-30-9 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 42.71
TPSA : 32.7 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.5 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.87
Log Po/w (XLOGP3) : -0.44
Log Po/w (WLOGP) : -0.68
Log Po/w (MLOGP) : -0.31
Log Po/w (SILICOS-IT) : 0.8
Consensus Log Po/w : 0.25

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.27
Solubility : 78.9 mg/ml ; 0.543 mol/l
Class : Very soluble
Log S (Ali) : 0.22
Solubility : 240.0 mg/ml ; 1.65 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.68
Solubility : 30.1 mg/ml ; 0.207 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.58

Safety of [ 4441-30-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 UN#:N/A
Hazard Statements:H227-H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4441-30-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4441-30-9 ]
  • Downstream synthetic route of [ 4441-30-9 ]

[ 4441-30-9 ] Synthesis Path-Upstream   1~20

  • 1
  • [ 110-91-8 ]
  • [ 627-18-9 ]
  • [ 4441-30-9 ]
YieldReaction ConditionsOperation in experiment
96% With potassium carbonate In toluene at 75 - 80℃; for 8 h; To the reaction bottle were added 913.5 g of toluene, 174 g of morpholine and 556 g of 3-bromopropanol, and 331.2 g of potassium carbonate was added under stirring,The reaction was heated at 75-80 ° C for 8 hours. After completion of the reaction, pressure filtration and concentration of the filtrate to remove toluene and unreacted raw materials, obtained light yellow278.4 g of N - (3-hydroxypropyl) morphorphine, a molar yield of 96percentGas purity was 98.5percent.
88.5% at 80℃; for 4 h; Morpholine 2a(3.1g, 36mmol) and 3-bromo-1-propanol (2.5g, 18mmol) were dissolved in 20mL of toluene at 80° C for 4 hours. The reaction was cooled to room temperature and the reaction was filtered. The filter cake was washed with ethyl acetate (2 mL X 2) and concentrated under reduced pressureThe filtrate gave the title product 3-morpholinopropan-1-ol 2b (2.3 g, yellow oil), yield: 88.5percent.
50% at 50℃; for 18 h; To a mixture of morpholine (33 mL, 371 mmol) and CH2C12(650 mL) was added 3-bromopropanol (25.8 g, 186 mmol), andthe mixture was heated at 50 °C for 18 h. The reaction wascooled, diluted with CH2C12/ and filtered. The filtrate waschromatographed (150 g SiC>2,; CH2C12 to 5percent 2 M NH3/MeOH inCH2C12) to give the title compound as a liquid (27.0 g,50percent) ..NMR (250 MHz, DMSO-dg) : 8 1.50(m, 2H) , 2.24(m, 6H), 3.36(t,J= 6.5 Hz, 1H) , 3.49(111, 2H) , 4.36(s, 1H) .FIA-MS, m/e: 146.1 (m+1).
Reference: [1] Patent: CN106045942, 2016, A, . Location in patent: Paragraph 0023; 0020
[2] Patent: CN103382206, 2016, B, . Location in patent: Paragraph 0235-0238
[3] Journal of Medicinal Chemistry, 2004, vol. 47, # 4, p. 871 - 887
[4] Patent: WO2004/108677, 2004, A1, . Location in patent: Page 141
[5] Patent: US6265411, 2001, B1,
[6] Patent: US6291455, 2001, B1,
[7] Patent: US6294532, 2001, B1,
[8] Patent: EP1171440, 2004, B1, . Location in patent: Page 50
  • 2
  • [ 196603-91-5 ]
  • [ 4441-30-9 ]
Reference: [1] Patent: US6291455, 2001, B1,
  • 3
  • [ 110-91-8 ]
  • [ 627-30-5 ]
  • [ 4441-30-9 ]
Reference: [1] Journal of Organic Chemistry, 1955, vol. 20, p. 855,858
[2] Journal of the American Chemical Society, 1942, vol. 64, p. 970,972
[3] Pharmazie, 1959, vol. 14, p. 201,202
[4] Journal of the American Chemical Society, 1949, vol. 71, p. 3366,3368
[5] Journal of the American Chemical Society, 1949, vol. 71, p. 3366,3368
[6] Journal of the American Pharmaceutical Association (1912-1977), 1951, vol. 40, p. 373,375
[7] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 21, p. 6875 - 6884
[8] Patent: US2795581, 1955, ,
  • 4
  • [ 20120-24-5 ]
  • [ 4441-30-9 ]
Reference: [1] Journal of Pharmaceutical Sciences, 1994, vol. 83, # 5, p. 644 - 648
[2] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 4, p. 1036 - 1040
  • 5
  • [ 33611-43-7 ]
  • [ 4441-30-9 ]
Reference: [1] Tetrahedron, 2007, vol. 63, # 52, p. 12903 - 12911
  • 6
  • [ 109-02-4 ]
  • [ 627-18-9 ]
  • [ 4441-30-9 ]
Reference: [1] Patent: US6355636, 2002, B1, . Location in patent: Page column 60
  • 7
  • [ 110-91-8 ]
  • [ 627-18-9 ]
  • [ 4441-30-9 ]
Reference: [1] Patent: US4791106, 1988, A,
  • 8
  • [ 503-30-0 ]
  • [ 110-91-8 ]
  • [ 4441-30-9 ]
Reference: [1] Tetrahedron Letters, 1994, vol. 35, # 5, p. 761 - 764
  • 9
  • [ 111-44-4 ]
  • [ 156-87-6 ]
  • [ 4441-30-9 ]
Reference: [1] Journal of the American Chemical Society, 1931, vol. 53, p. 2763,2767
  • 10
  • [ 110-91-8 ]
  • [ 693-03-8 ]
  • [ 4441-30-9 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 2789
  • 11
  • [ 111-44-4 ]
  • [ 109-78-4 ]
  • [ 4441-30-9 ]
Reference: [1] Patent: GB901187, 1958, ,
  • 12
  • [ 110-91-8 ]
  • [ 107-18-6 ]
  • [ 4441-30-9 ]
Reference: [1] Chemical Communications, 2015, vol. 51, # 35, p. 7459 - 7462
  • 13
  • [ 503-30-0 ]
  • [ 110-91-8 ]
  • [ 124-38-9 ]
  • [ 4441-30-9 ]
Reference: [1] Synthetic Communications, 1999, vol. 29, # 18, p. 3207 - 3214
  • 14
  • [ 23949-50-0 ]
  • [ 4441-30-9 ]
  • [ 2109-66-2 ]
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 40, p. 12796 - 12799
  • 15
  • [ 110-91-8 ]
  • [ 20907-32-8 ]
  • [ 4441-30-9 ]
Reference: [1] Yakugaku Zasshi, 1954, vol. 74, p. 763[2] Chem.Abstr., 1955, p. 11646
[3] Chemische Berichte, 1942, vol. 75, p. 123,129
  • 16
  • [ 696-57-1 ]
  • [ 4441-30-9 ]
  • [ 2109-66-2 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1980, vol. 2, # 11-12, p. 565 - 570
  • 17
  • [ 4441-30-9 ]
  • [ 7357-67-7 ]
Reference: [1] Tetrahedron, 2007, vol. 63, # 52, p. 12903 - 12911
[2] Journal of the American Chemical Society, 1957, vol. 79, p. 5667,5670
[3] Pharmaceutical Chemistry Journal, 1967, p. 463 - 467[4] Khimiko-Farmatsevticheskii Zhurnal, 1967, p. 35 - 39
[5] Patent: US2009/124624, 2009, A1, . Location in patent: Page/Page column 22
[6] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 21, p. 6875 - 6884
[7] Patent: US2795581, 1955, ,
  • 18
  • [ 4441-30-9 ]
  • [ 39969-57-8 ]
  • [ 637-58-1 ]
YieldReaction ConditionsOperation in experiment
82.61% With sodium hydride In tetrahydrofuran at 20℃; for 5 h; Reflux A 500 ml reaction flask was added with 23.2 g (0.1 mol) of the above intermediate.3-morpholine-1-propanol 17.42g (0.12 mol) and 115 g of tetrahydrofuran, with stirring turned on, slowly add 60percent sodium hydride 4.8g (0.12 mol), temperature below 20°C, about 1~2 min after addition,The reaction was heated to reflux and monitored by TLC. After about 5 hours, the reaction was completed. The solution was concentrated under reduced pressure. 60 ml of water was added and the pH was adjusted to 1 to 2 with concentrated hydrochloric acid.Ethyl acetate (100 ml) was washed twice. The aqueous layer was adjusted to pH 11-12 with 40percent sodium hydroxide, and the mixture was extracted twice with 120 ml of ethyl acetate.Combine the organic layers, dry an appropriate amount of anhydrous sodium sulfate, decolorize with 2g of charcoal, concentrate at 40°C without concentration, and dissolve with 80ml of methanol.Concentrated hydrochloric acid to adjust the pH 1~2, vacuum concentration to no more, add acetone 40ml dissolved, stirring crystallization, continue to cool to -10 ° C, stirring crystallization about 6 ~ 8 hours;The mixture was filtered with suction, washed with cold acetone, and dried at 45-50° C. for 6-8 hours to obtain 27.25 g of a white crystalline solid with a yield of 82.61percent, a purity of 99.926percent, and a maximum single impurity of 0.046percent.
Reference: [1] Patent: CN107892677, 2018, A, . Location in patent: Paragraph 0019; 0021
  • 19
  • [ 4441-30-9 ]
  • [ 367-21-5 ]
  • [ 865-47-4 ]
  • [ 162012-69-3 ]
  • [ 267243-68-5 ]
Reference: [1] Patent: US2003/158408, 2003, A1,
[2] Patent: US2003/50313, 2003, A1,
  • 20
  • [ 4441-30-9 ]
  • [ 267243-68-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2000, vol. 43, # 7, p. 1380 - 1397
[2] Patent: US2014/206687, 2014, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4441-30-9 ]

Alcohols

Chemical Structure| 5835-79-0

[ 5835-79-0 ]

4-Morpholinobutan-1-ol

Similarity: 0.85

Chemical Structure| 622-40-2

[ 622-40-2 ]

2-Morpholinoethanol

Similarity: 0.83

Chemical Structure| 103003-01-6

[ 103003-01-6 ]

Morpholin-2-ylmethanol

Similarity: 0.76

Chemical Structure| 1436436-17-7

[ 1436436-17-7 ]

(R)-Morpholin-2-ylmethanol hydrochloride

Similarity: 0.73

Chemical Structure| 144053-98-5

[ 144053-98-5 ]

Morpholin-2-ylmethanol hydrochloride

Similarity: 0.73

Related Parent Nucleus of
[ 4441-30-9 ]

Aliphatic Heterocycles

Chemical Structure| 1005-67-0

[ 1005-67-0 ]

4-Butylmorpholine

Similarity: 0.88

Chemical Structure| 5835-79-0

[ 5835-79-0 ]

4-Morpholinobutan-1-ol

Similarity: 0.85

Chemical Structure| 622-40-2

[ 622-40-2 ]

2-Morpholinoethanol

Similarity: 0.83

Chemical Structure| 141814-57-5

[ 141814-57-5 ]

(4-Methylmorpholin-2-yl)methanamine

Similarity: 0.82

Chemical Structure| 122894-56-8

[ 122894-56-8 ]

N,N-Dimethyl-1-(morpholin-2-yl)methanamine

Similarity: 0.82

Morpholines

Chemical Structure| 123-00-2

[ 123-00-2 ]

3-Morpholinopropan-1-amine

Similarity: 0.92

Chemical Structure| 1005-67-0

[ 1005-67-0 ]

4-Butylmorpholine

Similarity: 0.88

Chemical Structure| 5835-79-0

[ 5835-79-0 ]

4-Morpholinobutan-1-ol

Similarity: 0.85

Chemical Structure| 622-40-2

[ 622-40-2 ]

2-Morpholinoethanol

Similarity: 0.83

Chemical Structure| 122894-56-8

[ 122894-56-8 ]

N,N-Dimethyl-1-(morpholin-2-yl)methanamine

Similarity: 0.82